Chrome Extension
WeChat Mini Program
Use on ChatGLM

MP64-01 PATIENT REPORTED QUALITY OF LIFE MEASURES 15 YEARS POST-RADICAL PROSTATECTOMY: A MATCHED COMPARISON OF OPEN RETROPUBIC AND ROBOT ASSISTED TECHNIQUES

The Journal of Urology(2020)

Cited 0|Views11
No score
Abstract
You have accessJournal of UrologyProstate Cancer: Epidemiology & Natural History II (MP64)1 Apr 2020MP64-01 PATIENT REPORTED QUALITY OF LIFE MEASURES 15 YEARS POST-RADICAL PROSTATECTOMY: A MATCHED COMPARISON OF OPEN RETROPUBIC AND ROBOT ASSISTED TECHNIQUES Tristan Juvet, Malek Meskawi, Kevin Wymer, Laureano Rangel, Paige Nichols, Stephen Boorjian, Igor Frank, Jeffrey Karnes, R Houston Thompson, Matthew Tollefson, Matthew Gettman, and Nicole Dodge* Tristan JuvetTristan Juvet More articles by this author , Malek MeskawiMalek Meskawi More articles by this author , Kevin WymerKevin Wymer More articles by this author , Laureano RangelLaureano Rangel More articles by this author , Paige NicholsPaige Nichols More articles by this author , Stephen BoorjianStephen Boorjian More articles by this author , Igor FrankIgor Frank More articles by this author , Jeffrey KarnesJeffrey Karnes More articles by this author , R Houston ThompsonR Houston Thompson More articles by this author , Matthew TollefsonMatthew Tollefson More articles by this author , Matthew GettmanMatthew Gettman More articles by this author , and Nicole Dodge*Nicole Dodge* More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000939.01AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Robotically assisted radical prostatectomy (RARP) has become the most common surgical treatment option for clinically localized prostate cancer in the United States. Controversy continues to exist over the benefits of a robotic approach versus open radical retropubic prostatectomy (RRP). Previous studies have failed to show a difference in oncologic or functional outcomes. Short term quality of life studies have also failed to show a significant difference between the two options. We report data on 15 years of follow up using standardized quality of life questionnaires. METHODS: Survey data was obtained from patients who underwent treatment for clinically localized prostate cancer from August 2002 to December 2005. Patients were matched 2:1 for surgical year, age, preoperative PSA, clinical stage and biopsy Gleason grade. Patients were asked to fill out and return 3 standardized questionnaires sent as a package: SF-12, EORTC QLQ-30 and EPIC-26 SF. Four additional questions were also added to our survey regarding the use of erectile therapies and surgical treatments for erectile dysfunction and urinary incontinence. RESULTS: 452 patients completed and returned the survey. This included 156 patients treated with RARP, matched to 296 patients treated by RRP. Response rate was 70%. There were no significant differences in clinicopathologic characteristics between both groups. In review of all three questionnaires, a significant difference was only noted in the number of pads/diapers required in the past 4 weeks (p=0.04). The overall rate of patients reporting surgical treatments for incontinence (9/452, 2.1%) and erectile dysfunction (3/452, 0.7%) were very low with no significant difference between RARP and RRP. CONCLUSIONS: There continues to exist few differences in quality of life measures between RARP and RRP at long term follow up. Key components of the survey involving sexual function and continence showed no significant difference at 15 years follow up. This represents one of the longest follow up periods to date comparing these treatment modalities. All additional variables regarding multiple facets of quality of life measures showed no long term differences between both subgroups. Source of Funding: None © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e963-e963 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Tristan Juvet More articles by this author Malek Meskawi More articles by this author Kevin Wymer More articles by this author Laureano Rangel More articles by this author Paige Nichols More articles by this author Stephen Boorjian More articles by this author Igor Frank More articles by this author Jeffrey Karnes More articles by this author R Houston Thompson More articles by this author Matthew Tollefson More articles by this author Matthew Gettman More articles by this author Nicole Dodge* More articles by this author Expand All Advertisement PDF downloadLoading ...
More
Translated text
Key words
Prostate Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined